NOT-CA-18-093: Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"

Notice of Change to Key Dates in PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)"

Notice Number: NOT-CA-18-093

Key Dates
Release Date: September 13, 2018

Related Announcements
PAR-18-249

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to revise the Key Dates for PAR-18-249 "Quantitative Imaging Tools and Methods for Cancer Response Assessment (U01 Clinical Trial Optional)".

Part 1. Key Dates

Currently reads:

Application Due Date(s): May 9, 2018; September 12, 2018; January 9, 2019; May 9, 2019; September 12, 2019; January 9, 2020

Scientific Merit Review: August 2018; February 2019; June 2019; August 2019; February 2020; June 2020;

Advisory Council Review: January 2019; May 2019; August 2019; January 2020; May 2020; August 2020

Earliest Start Date: April 2019; July 2019; September 2019; April 2020; July 2020; September 2020

Expiration Date: January 10, 2020

Modified to read:

Application Due Date(s): May 9, 2018; September 12, 2018

Scientific Merit Review: August 2018; February 2019

Advisory Council Review: January 2019; May 2019

Earliest Start Date: April 2019; July 2019

Expiration Date: September 13, 2018

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Robert J. Nordstrom, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-5934
Email: [email protected]

Darrell Tata, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276 5894
Email: [email protected]

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]

Dianna N. Bailey
National Cancer Institute (NCI)
Telephone: 240-276-6179
Email: [email protected]